Back to top

Novo Nordisk Adds a New Early-Stage Obesity Drug to Its Pipeline

Novo Nordisk ($NVO) announced an update on their ongoing clinical study. Novo Nordisk A/S (NVO) is running a Phase 1 study called “An NNC6022-0004 ...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Novo Nordisk A/S (NVO)